Table 1 Lab results of first admission and follow up visits
| Â | Pre IVIG Treatment | Two weeks from the onset | Three months from the onset | Six months from the onset | Nine months from the onset | Nine months from the onset | Nine months from the onset |
|---|---|---|---|---|---|---|---|
WBC 103/micl | 15.1 | 9.6 | — | — | — | — | — |
RBC 106/micl | 3.8 | 4.11 | — | — | — | — | — |
Hemoglobin g/dl | 9.8 | 11 | — | — | — | — | — |
MCV fl | 78.8 | 79 | — | — | — | — | — |
Platelet 103/micL | 519 | 362 | — | — | — | — | — |
ESR mm/hr | 60 | 5 | — | — | — | — | — |
CRP mg/L | 45 | 1 | — | — | — | — | — |
CPK mcg/L | 150 | 183 | 94 | 98 | 92 | 99 | 70 |
LDH IU/L | 417 | 309 | 268 | 284 | 280 | 283 | 191 |
AST U/L | 351 | 252 | 198 | 205 | 230 | 212 | 197 |
ALT U/L | 40 | 17 | 11 | 12 | 15 | 15 | 17 |
ALP U/L | 485 | 213 | 215 | 190 | 204 | 201 | 313 |
GGT U/L | 30 | 13 | 8 | 7 | 10 | 12 | 9 |
ALB g/dl | 4 | 4.4 | 4 | 4.2 | 4.8 | 4.7 | 3.9 |
Total Protein g/dl | 7 | 6.9 | 6 | 6.4 | 6.9 | 6.8 | 6.3 |
PT Sec/INR | 13/1 | 13.1 | 13/1 | 13/1 | 13.5/1.1 | 13/1 | 12/1 |
PTT Sec | 37 | 37.5 | 38 | 38.5 | 39.6 | 37 | 35 |
Other complementary test | |||||||
 ANA | Neg | HBS Ag | Neg | Retic | 2.2% |  |  |
 Anti LKM | < 1.0 Ru/ml | IgM Anti HBC | Neg | Coombs | Neg |  |  |
 Anti Smooth Muscle Ab | Neg | Anti HCV | Neg | Indirect Coombs | Neg |  |  |
 Anti TTG IgA | < 1 Ru/ml | Anti HIV | Neg | G6PD | Sufficient |  |  |
 IgA | 137 mg/dl | Ammonia | 0.89 Microg/ml | Hemoglobin A | 95.2% |  |  |
 Ceruloplasmin | 39 mg/dl | Lactate | 21.3 mg/dl | Hemoglobin A2 | 3% |  |  |
 Alfa 1 Antitrypsin | 151 mg/dl | Triglycerides | 58 mg/dl | Hemoglobin F | 1.8% |  |  |
 TSH | 10.22 micg/dl | Cholesterol | 163 mg/dl | Ferritin | 27.78 ng/ml |  |  |